- In Memoriam
- About
- Apply
- People
- Education
- Events
- Articles
-
News
News Fatty Liver Foundation Announces Second Cohort of the Dr. Stephen A. Harrison Patient Advocacy Fellowship Fatty Liver Foundation Opens Applications for Year 2 of the Dr. Stephen A. Harrison Patient Advocacy Fellowship Harrison Fellowship Highlights Patient Advocate Engagement at Liver Forum 20 Harrison Fellows Engage at 10th Annual MASH-TAG Conference Harrison Fellows Convene at AASLD’s The Liver Meeting® 2025 The Dr. Stephen A. Harrison Patient Advocacy Fellowship Program on Surfing the MASH Tsunami Fatty Liver Foundation to Introduce Dr. Stephen A. Harrison Patient Advocacy Fellowship at Liver Forum 19 in Paris, France Fatty Liver Foundation Announces Inaugural Cohort of the Dr. Stephen A. Harrison Patient Advocacy Fellowship Fatty Liver Foundation Launches Groundbreaking Patient Advocacy Fellowship Honoring Dr. Stephen A. Harrison
- FAQ
- Contact
Fellows 2026-2027
Meet New Harrison Fellows
The Dr. Stephen A. Harrison Patient Advocacy Fellowship is pleased to welcome its second cohort of Fellows.
Selected through a competitive process led by an independent Selection Committee, these 20 patient advocates bring diverse experiences, perspectives, and a shared commitment to strengthening the patient voice in liver disease research, drug development, and health policy.
Representing communities across the United States, United Kingdom, Portugal, and Spain, the Fellows bring lived experience spanning the spectrum of steatotic liver disease (SLD), including MASLD, MASH, MetALD, and alcohol-associated liver disease (ALD).
2026–2027 Harrison Fellows
-
Lori Botello — Tucson, Arizona, USA
-
Jim Caldwell — Georgetown, Texas, USA
-
Willis Frank Dungan — Central Mississippi, USA
-
Dianne Gillard — London, United Kingdom
-
D. Scott Graham — Manassas, Virginia, USA
-
Jo Anne Henry — Roanoke, Virginia, USA
-
Kathryn J. Hudson — Baltimore, Maryland, USA
-
Gema Iribar — Zarautz, Spain
-
Karen V. Kwinn — Denver, Colorado, USA
-
Georgeta Lester — Raleigh, North Carolina, USA
-
Wendy Lo — San Francisco, California, USA
-
Lesley Anne Manning — Plymouth, United Kingdom
-
Gary Miller — Stamford, Connecticut, USA
-
Terri Milton — Houston, Texas, USA
-
Tricia Nichols — Murfreesboro, Tennessee, USA
-
Joana Pina — Vila Real, Portugal
-
Jerry Rosenberg — Jacksonville, Florida, USA
-
Jillian Sanchez — McAllen, Texas, USA
-
Claudia S. Tamayo-Torres — Brighton, Massachusetts, USA
-
Ken Wong — San Ramon, California, USA
A Year of Learning, Collaboration, and Advocacy
Throughout the Fellowship year, participants will engage in structured educational sessions, mentorship, professional networking, and applied advocacy activities designed to strengthen their understanding of clinical research and regulatory decision-making.
Building on the foundation established by the inaugural cohort, the 2026–2027 Fellows will continue advancing Dr. Stephen A. Harrison's legacy of ensuring that patients are active partners in shaping the future of liver disease research and treatment.